#South Korea #Seoul #Hypertension #Sky Labs #CART BP pro

Sky Labs’ CART BP Pro: A Global Game Changer in Health Monitoring

Sky Labs, under the leadership of CEO Jack ByungHwan Lee, has made significant strides in the healthcare sector with its groundbreaking device, the CART BP Pro. Recently, this innovative blood pressure monitoring system was lauded by international experts during exclusive symposiums held at major healthcare conferences in Europe, specifically at the 35th Congress of the European Society of Hypertension in Gdansk, Poland, and the British Cardiovascular Society Annual Conference in Manchester, England.

The timing of these symposiums was crucial, coming right after the Korean Society of Hypertension updated its hypertension guidelines in May 2026. For the first time, these guidelines officially suggested that validated cuffless blood pressure monitors should be considered for monitoring outside of the clinical settings. This recommendation positions South Korea as a leader in the clinical application of cuffless monitoring, putting CART BP Pro at the forefront of international medical discussions.

The Significance of CART BP Pro

CART BP Pro has demonstrated a remarkable ability to adhere to international standards, specifically ISO 81060-2:2018, in comparative studies with traditional measurement methods. The device continuously builds its clinical evidence base, meeting stringent recommendations set by the European Society of Hypertension for cuffless blood pressure monitors, including static testing, positioning tests, wake/sleep studies, and stress tests. Such robust validation led to its rapid adoption within South Korean medical institutions, boasting over 260,000 prescriptions as of May 2026.

Prominent figures in the field, such as Professor George Stergiou, President of the International Society of Hypertension, have acknowledged the role of South Korea as a pioneer in the practical clinical application of cuffless blood pressure devices. He noted the importance of evaluating not just the device's measurement accuracy, but also its impact on patient prognosis, adherence to therapy, and overall blood pressure management.

Similarly, Professor Carmel McEniery from the University of Cambridge praised the system's clinical environment in South Korea, highlighting how it is well ahead of its time in adopting cuffless technologies. Professor Philip Lewis emphasized that CART BP Pro's ability to collect reliable data around the clock—day and night—provides a significant advantage over traditional cuff-based methods, indicating its potential for broader clinical applications beyond hypertension management.

Patient-Centric Approach

The design of CART BP Pro focuses heavily on patient comfort, as explained by Professor Geu-Ru Hong from the Cardiovascular Department at Severance Cardiovascular Hospital. The cuffless device minimizes disruptions during sleep that are typically caused by the pressure from conventional cuffs, offering a more comfortable and satisfying experience for patients.

South Korea's infrastructural support, characterized by low out-of-pocket expenses for 24-hour blood pressure monitoring and a well-established health insurance system, provides an ideal environment for the introduction of innovative medical products. Professor Kwang-Il Kim, President of the Korean Society of Hypertension, remarked on how these factors facilitate a swift rollout of such devices in clinical practice.

Future Prospects and Expansion Plans

Earlier in January 2026, Sky Labs received the European CE-MDR certification for CART BP Pro, followed by its product registration with the UK's Medicines and Healthcare Products Regulatory Agency (MHRA). These regulatory milestones have set the stage for Sky Labs to broaden its activities across European markets, including the United Kingdom, thereby strengthening its global position in the healthcare industry.

Sky Labs, founded in September 2015, focuses on the development and operation of CART, which serves as a ring-shaped device for ongoing patient monitoring with chronic conditions. Following the successful introduction of CART BP Pro and a consumer-oriented blood pressure monitor launched in September 2025, the company is poised to expand its reach and impact significantly in the field of health monitoring.

Media Contact

For media inquiries or more information about Sky Labs and its products, please reach out to:

• - Inok Jung: [email protected]
• - Bomi Lee: [email protected]

In conclusion, as CART BP Pro continues to pave its way in the medical landscape, it promises not only to enhance the management of hypertension but also to transform patient monitoring standards worldwide.